Pharma Bio Serv (OTCMKTS:PBSV) and Huron Consulting Group (NASDAQ:HURN) are both small-cap business services companies, but which is the superior business? We will contrast the two businesses based on the strength of their earnings, profitability, institutional ownership, valuation, dividends, analyst recommendations and risk.
Pharma Bio Serv pays an annual dividend of $0.08 per share and has a dividend yield of 8.0%. Huron Consulting Group does not pay a dividend. Pharma Bio Serv pays out -160.0% of its earnings in the form of a dividend.
This table compares Pharma Bio Serv and Huron Consulting Group’s net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
|Pharma Bio Serv||23.60%||8.63%||6.95%|
|Huron Consulting Group||2.27%||9.44%||4.77%|
This is a breakdown of recent ratings for Pharma Bio Serv and Huron Consulting Group, as reported by MarketBeat.com.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
|Pharma Bio Serv||0||0||0||0||N/A|
|Huron Consulting Group||0||0||3||0||3.00|
Huron Consulting Group has a consensus target price of $58.33, indicating a potential upside of 23.35%. Given Huron Consulting Group’s higher probable upside, analysts plainly believe Huron Consulting Group is more favorable than Pharma Bio Serv.
Institutional and Insider Ownership
90.6% of Huron Consulting Group shares are owned by institutional investors. 51.6% of Pharma Bio Serv shares are owned by company insiders. Comparatively, 2.9% of Huron Consulting Group shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.
Volatility and Risk
Pharma Bio Serv has a beta of 0.24, suggesting that its stock price is 76% less volatile than the S&P 500. Comparatively, Huron Consulting Group has a beta of -0.04, suggesting that its stock price is 104% less volatile than the S&P 500.
Earnings and Valuation
This table compares Pharma Bio Serv and Huron Consulting Group’s gross revenue, earnings per share and valuation.
|Gross Revenue||Price/Sales Ratio||Net Income||Earnings Per Share||Price/Earnings Ratio|
|Pharma Bio Serv||$17.80 million||1.31||$1.27 million||($0.05)||-20.00|
|Huron Consulting Group||$878.00 million||1.23||$13.65 million||$2.08||22.74|
Huron Consulting Group has higher revenue and earnings than Pharma Bio Serv. Pharma Bio Serv is trading at a lower price-to-earnings ratio than Huron Consulting Group, indicating that it is currently the more affordable of the two stocks.
Huron Consulting Group beats Pharma Bio Serv on 8 of the 15 factors compared between the two stocks.
About Pharma Bio Serv
Pharma-Bio Serv, Inc. operates as a compliance and technology transfer services consulting firm the United States, Europe, and Brazil markets. It provides compliance consulting services to the pharmaceutical, chemical, biotechnology, medical device, cosmetic, food industries, and allied products in Puerto Rico, the United States, Europe, and Brazil. The company's technical consulting services comprise regulatory compliance, validation, technology transfer, engineering, project management, and process support. Pharma-Bio Serv, Inc. was founded in 1993 and is headquartered in Dorado, Puerto Rico.
About Huron Consulting Group
Huron Consulting Group Inc., a professional services firm, provides advisory, technology, and analytic solutions in the United States and internationally. Its Healthcare segment provides advisory services in the areas of strategy, care transformation, financial and operational excellence, technology and analytics, and leadership development to national and regional hospitals, integrated health systems, academic medical centers, community hospitals, and medical groups. The company's Education segment offers consulting and technology solutions related to business and technology strategy, financial management, operational and organizational effectiveness, research administration, and regulatory compliance for higher education institutions and academic medical centers. Its Business Advisory segment provides capital advisory, transaction advisory, operational improvement, restructuring and turnaround, valuation, and dispute advisory services; technology and analytic solutions that enable organizations to manage their financial performance, operational efficiency, and client or stakeholder experience; and strategic solutions to pharmaceutical, medical device, and biotechnology companies. This segment provides its services to organizations, not-for-profit organizations, lending institutions, law firms, investment banks, and private equity firms. The company serves the healthcare, education, pharmaceutical, biotech and medical device, financial services, energy and utilities, retail, aerospace, automotive, technology, telecommunications, consumer products, governmental, metals and mining, engineering and construction, hospitality and gaming, logistics, and manufacturing industries. Huron Consulting Group Inc. was founded in 2002 and is headquartered in Chicago, Illinois.
Receive News & Ratings for Pharma Bio Serv Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pharma Bio Serv and related companies with MarketBeat.com's FREE daily email newsletter.